NYLIM
FOLD

New York Life Investment Management’s Amicus Therapeutics FOLD Stock Holding History

New York Life Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-306,400
Closed -$4.43M – 799
2026
Q1 		$4.43M Buy
+306,400
New +$4.39M 0.04% 347

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's FOLD Position: Q2 2026 in Review

New York Life Investment Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 306,400 shares — an estimated $4.43M sold.

New York Life Investment Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $4.43M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • New York Life Investment Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • New York Life Investment Management sold 306,400 Amicus Therapeutics shares in Q2 2026, an estimated $4.43M.
  • New York Life Investment Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • New York Life Investment Management's Amicus Therapeutics position peaked at $4.43M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.